In our previous study, we identified a simple CD11b-CD169-based myeloid response score (MRS) by screening nine myeloid markers which covered the main tumor-infiltrating myeloid subtypes, and constructed MRS-based predictive nomograms to predict the prognosis of postoperative HCC patients (Wu et al., 2020). This evidence concerns the gene SIGLEC1 and hepatocellular carcinoma.